Related by context. Frequent words. (Click for all words.) 68 HepaLife Technologies Inc. 68 Roche SIX RO 68 NASDAQ CRXL 67 MorphoSys AG FSE MOR 67 Nasdaq CRXL 66 commercializing therapeutic 66 Crucell NV Euronext 66 theranostic 66 novel antibody therapeutics 66 Genaera Corporation 65 Agios Pharmaceuticals 65 immunotherapeutics 65 Inc. Nasdaq IMGN 65 Exploit collaboration 65 ImmunoCellular Therapeutics Ltd. 65 bio therapeutics 65 OTCBB NEOP diversified 65 Nasdaq ENZN 65 theranostics 64 Sanofi aventis EURONEXT SAN 64 imaging neurodegenerative disorders 64 therapeutic monoclonal antibodies 64 Inc. Nasdaq SUPG 64 Nasdaq VRTX 64 inflammation autoimmune diseases 64 Archemix Corp. 64 StromaCel Inc. 64 NASDAQ OSIR 64 TSX TKM 64 ImmuneRegen BioSciences Inc. 64 autologous adult 63 Celsion Corporation 63 Initiates Phase II 63 Pervasis 63 CardioVascular BioTherapeutics Inc. 63 VIA Pharmaceuticals 63 immuno inflammatory diseases 63 Inc. NASDAQ ANPI 63 NASDAQ SNTA biopharmaceutical 63 Idera Pharmaceuticals 63 Inc. Nasdaq NEXM 63 PVCT 63 NASDAQ DYAX 63 Adeona Pharmaceuticals Inc. 63 Ceragenix Pharmaceuticals Inc. 62 Nasdaq OSIP 62 developing Zerenex TM 62 BiTE R 62 Lipid Sciences Inc. 62 Regado Biosciences 62 OTCQX RHHBY 62 NASDAQ LGND 62 ChondroGene 62 vascular disorders 62 NovaBay Pharmaceuticals 62 Inc. OTCBB PWRM 62 Sangamo BioSciences 62 cystic fibrosis inflammation autoimmune 62 EnVivo Pharmaceuticals 62 Nasdaq ENMD 62 Nasdaq ISIS 62 Nasdaq REGN 62 neurovascular diseases 62 Adherex Technologies Inc. 62 Novelos Therapeutics Inc. 62 novel RNAi therapeutics 62 immunologic diseases 62 R sorafenib tablets 62 Omeros Corporation 62 Rosetta Genomics Ltd. 62 Group NV Pharming 62 phenylketonuria PKU developed 62 Urigen Pharmaceuticals Inc. 62 MultiCell Technologies 62 molecular biomarkers 61 AACR publishes five 61 NASDAQ IMCL 61 Panzem R 61 MacuSight 61 NASDAQ AEZS 61 peptide therapeutics 61 Actelion Ltd 61 Inc. NASDAQ CLDA 61 Microplasmin 61 Vaccinex 61 BioMarin develops 61 Medtech Insight division 61 autoimmune inflammatory 61 Cardium Therapeutics Inc. 61 Therapeutic Competitors 61 Response Genetics Inc. 61 Nasdaq ALXN 61 Paris EURONEXT SAN 61 fibrosis IPF 61 addressing idiopathic pulmonary 61 * Azixa 61 oncolytic viruses 61 Inc. NASDAQ QLTI 61 Inc. NASDAQ TRGT 61 Fluidigm Corporation 61 Nasdaq ASTM